CYTOKINETICS INC
Late-stage biopharma developing muscle-modulating drugs for heart and neuromuscular diseases.
CYTK | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 350 OYSTER POINT BOULEVARD, 94080 SOUTH SAN FRANCISCO
- Website:
- https://cytokinetics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Cytokinetics, Inc. is a late-stage biopharmaceutical company pioneering the science of muscle biology. The company is dedicated to the discovery, development, and commercialization of novel small molecule therapeutics designed to modulate muscle function and contractility. Its research and development efforts target debilitating diseases characterized by impaired muscle performance, with a primary focus on cardiovascular conditions such as heart failure and hypertrophic cardiomyopathy (HCM), as well as neuromuscular disorders. As a leader in its field for over 25 years, Cytokinetics advances a pipeline of muscle activators and inhibitors through late-stage clinical trials and toward regulatory submission, aiming to improve healthspan and outcomes for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all CYTOKINETICS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CYTOKINETICS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CYTOKINETICS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
